Miles Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Miles Capital's GILD Position: Q1 2020 in Review
Miles Capital increased its Gilead Sciences (GILD) stake by 1.5% in Q1 2020, buying an estimated $13K and bringing the position to 12,900 shares worth $964K. The position accounts for 1.04% of the portfolio, ranked #21.
Miles Capital first reported a position in GILD in Q2 2016 and has held it in 16 quarters since. The position peaked at $1.45M in Q2 2017. 1,642 funds tracked by Wall St. Rank hold GILD as of Q1 2020.
- Miles Capital held 12,900 shares of Gilead Sciences worth $964K as of Q1 2020.
- Miles Capital bought 188 Gilead Sciences shares in Q1 2020, an estimated $13K.
- Gilead Sciences made up 1.04% of Miles Capital's portfolio in Q1 2020, its #21 holding.
- Miles Capital first reported a position in Gilead Sciences in Q2 2016 and has held it in 16 quarters since.
- Miles Capital's Gilead Sciences position peaked at $1.45M in Q2 2017.
- 1,642 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.
Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.